Mayne Pharma Group Ltd (ASX:MYX) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.56 and traded as high as $0.56. Mayne Pharma Group shares last traded at $0.55, with a volume of 2,943,221 shares.

The firm has a market capitalization of $772.79 million and a P/E ratio of -2.55. The company has a debt-to-equity ratio of 36.47, a quick ratio of 1.64 and a current ratio of 2.23. The business has a 50 day simple moving average of A$0.56 and a two-hundred day simple moving average of A$0.55.

Mayne Pharma Group Company Profile (ASX:MYX)

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers.

Recommended Story: What is diluted earnings per share (Diluted EPS)?

Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.